![]() Needle-Free Devices: Technologies and Global Markets
Report Scope Both qualitative and quantitative data on the current market dynamics and trends are presented in this report on the global market for needle-free devices. The report also assesses re... もっと見る
SummaryReport ScopeBoth qualitative and quantitative data on the current market dynamics and trends are presented in this report on the global market for needle-free devices. The report also assesses recent technological developments and product performance. Analyses of the most popular products, clinical trials, new product approvals, and emerging technologies are also included. The market prospects for five regions—North America, Europe, Asia-Pacific, South America, and the Middle East and Africa (MEA)—are discussed. The report also includes profiles of leading companies and their strategies. The global market is segmented into the following product types: needle-free injectors, inhaler technologies, transdermal patch technologies and other novel technologies. By application, the market is segmented into vaccines, pain management, insulin delivery, pediatric injections and others. By end-user, the market is segmented into hospitals and clinics, homecare settings, and research and academic institutions. For market estimates, data has been provided for 2024 as the base year, with forecasts for 2025 through 2030. Report Includes - 49 data tables and 56 additional tables - An overview of the global market for needle-free devices and technologies - Analyses of global market trends with data from 2022 to 2025 and projected CAGRs through 2030 - Highlights of the current and future market potential and quantification of the market by product type, application, end user and region - Assessment of the recent developments, key technological updates and product performance within the needle-free devices market - Insight into various needle-free technologies that are used in drug delivery and their application areas - Discussion of government regulations that can affect the global needle-free devices market - Identification of challenges and discussion on how to overcome those to reach its commercialization potential, and ESG trends of the market - Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis - Company profiles of major players within the industry, including GSK plc., Novartis AG, Viatris Inc., and PharmaJet Table of ContentsTable of ContentsChapter 1 Executive Summary Market Outlook Scope of Report Market Summary Chapter 2 Market Overview Overview Macroeconomic Factors Impact of U.S. Tariffs on the Pharmaceutical and Medical Device Industries Population Demographics and Aging Populations Healthcare Infrastructure and Spending Regulatory and Policy Landscape Technological Advances and Funding Geopolitical Risks, Trade Wars, and Supply Chain Disruptions Porter’s Five Forces Analysis Potential for New Entrants (Moderate to High) Bargaining Power of Suppliers (Low to Moderate) Bargaining Power of Buyers (Moderate to High) Threat of Substitute Products or Services (High) Industry Level of Competitiveness (Moderate to High) Chapter 3 Market Dynamics Overview Market Drivers Increasing Incidence of Needlestick Injuries Preference for Painless Drug Delivery Demand for Home Healthcare and Self-Administration Market Restraints Cost of Needle-Free Technology Limitations of Large Volume and Intravenous Administration Systems Market Opportunities Product Innovation Increased Investments in Healthcare in Emerging Markets Chapter 4 Regulatory Landscape Overview Regulatory Scenario in the U.S. Regulatory Scenario in Europe Regulatory Scenario in Japan Regulatory Scenario in China FDA-Approved Inhalers FDA-Approved Transdermal Patch Chapter 5 Emerging Trends and Pipeline Analysis Emerging Trends Smart Patches Smart Inhalers Sonophoresis 3D-Printed Microarray Patches Dissolving/Degradable Patches Pipeline Analysis Takeaways Patent Analysis Inhaler Technologies Transdermal Patches Needle-Free Injectors Findings Chapter 6 Market Segmentation Analysis Segmentation Breakdown Market Breakdown by Product Type Takeaways Inhaler Technologies Transdermal Patches Needle-free Injectors Other Novel Technologies Market Breakdown by Application Takeaways Vaccines Pain Management Insulin Delivery Pediatric Drug Delivery Other Applications Market Breakdown by End-User Takeaways Hospital and Clinics Homecare Settings Research and Academic Institutions Geographic Breakdown Market Breakdown by Region Key Takeaways North America Europe Asia-Pacific South America Middle East and Africa Chapter 7 Competitive Intelligence Takeaways Market Shares of Leading Companies Strategic Analysis Chapter 8 Sustainability in Needle-Free Devices: ESG Perspective Overview Environmental Sustainability Social Responsibility Governance Perspective ESG Risk Ratings Concluding Remarks from BCC Research Chapter 9 Appendix Research Methodology Sources Abbreviations Company Profiles AKRA DERMOJET APTARGROUP INC. ARX LLC. ASTRAZENECA AVAXZIPEN CROSSJECT ENDO INC. GSK PLC. HALOZYME INC. MIKA MEDICAL CO. NOVARTIS AG NUGEN MEDICAL DEVICES PHARMAJET PRESSPART VERWALTUNGS GMBH VIATRIS INC. Emerging Start-ups/Market Disruptors
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
BCC Research社の健康維持分野での最新刊レポート
本レポートと同じKEY WORD(devices)の最新刊レポート
よくあるご質問BCC Research社はどのような調査会社ですか?BCCリサーチ(BCC Research)は1971年に設立され、様々な業界経験を持つアナリストと編集者によりトップクラスの市場情報源を長年提供している調査会社です。 設立初期は先端材料とプラ... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|